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Recently we demonstrated that the radical nitric oxide (NO) stimulates the auto-ADP-ribosylation of the glycolytic enzyme glyceraldehyde-3- 
phosphate dehydrogenase (GAPDH) resulting in enzyme inhibition. To further characterize this auto-ADP-ribosylation reaction we studied alcohol 
dehydrogenase (ADH) and lactate dehydrogenase (LDH) for comparison. Whereas auto-ADP-ribosylation of ADH was stimulated to a minor 
extent by the NO-liberating agent 3-morpholinosydnonimine (SIN-l), LDH was unaffected. The susceptibility of dehydrogenases towards auto- 
ADP-ribosylation correlated with the potency of NO to decrease nzyme activity. Again, GAPDH was much more sensitive compared to ADH, 
whereas LDH again was unaffected. Interestingly, the efficiency of the SH-alkylating agent N-ethylmaleimide (NEM) to inhibit the enzymatic 
activity of the chosen dehydrogenases correlates with the sensitivity of dehydrogenases towards NO. These studies demonstrate the requirement 
of a reactive SH-group besides the NAD’ binding site as a prerequisite for NO-stimulated auto-ADP-ribosylation reactions. Furthermore, we 
establish that under physiological conditions and among the dehydrognases tested, only GAPDH is a potential target for this post-translational 
protein modification mechanism. 
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1. INTRODUCTION 
Nitric oxide (NO) is produced in various mammalian 
cells by the enzymatic activity of NO-synthases, cata- 
lysing the generation of NO from the terminal guani- 
dino nitrogen atom of L-arginine [1,2]. On one hand, 
NO produced by the calcium regulated constitutive NO- 
synthase is involved in many physiological processes, 
including regulation of vascular tone and platelet aggre- 
gation, furthermore functioning as a signaling pathway 
in the nervous system [24]. In this respect NO actions 
are mediated by binding to the iron-containing heme 
group of soluble guanylyl cyclase, thus increasing 
cGMP levels [5]. On the other hand, large amounts of 
NO are produced under pathophysiological conditions 
by the cytokine inducible NO-synthase [6]. Cytotoxic 
effects of NO are mediated by this long-lasting, high- 
output system. NO functions as a cytotoxic effector 
molecule by destructing several iron-containing enzy- 
matic activities including aconitase [7], mitochondrial 
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electron transfer proteins [8] and ribonucleotide reduc- 
tase [9]. 
Besides interfering with heme and non-heme iron 
containing enzymes, we reported that NO stimulates the 
auto-ADP-ribosylation of the glycolytic enzyme glycer- 
aldehyde-3-phosphate-dehydrogenase (GAPDH) 
[lO,l 11. NO induces the transfer of ADP-ribose from 
NAD’ to a cysteine residue of GAPDH, thereby inhib- 
iting enzyme activity [12]. Although the exact reaction 
mechanism is not yet fully understood, NO first seems 
to interact with a cysteine residue, possibly at the active 
site, and in a second step promotes the ADP-ribose 
transfer reaction from NAD’, which is bound close to 
the active cysteine group at the nearby NAD+ binding 
site [12]. 
To further characterize the auto-ADP-ribosylation 
reaction of GAPDH, we studied other dehydrogenases 
in order to determine the requirement of a reactive SH- 
group in combination with a nearby NAD’ binding site 
as a prerequisite for this new type of NO-stimulated 
post-translational protein modification mechanism. 
2. MATERIALS AND METHODS 
2.1. Materzals 
[“PINAD+ (800 Ci/mmol) was purchased from Du Pont-New Eng- 
land Nuclear. SIN-1 was provided by Cassella-Pharma, Frankfurt, 
Germany, while ADH and GAPDH were from Sigma. All other chem- 
icals were of the highest grade of purity available, mainly delivered by 
Boehringer Mannheim, Germany. 
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2.2. Enzyme activrty determination LDH ADH GAPDH 
GAPDH activity was measured as outlined in reference [l 11. Assays 
contained 50 mM triethylamine (pH 7.6). 50 mM arsenate, 100 &ml 
glyceraldehyde 3-phosphate and 2 mM glutathione. Incubations were 
carried out in the presence of 400 mU of rabbit muscle GAPDH at 
37°C for 30 min with 1 PM NAD’, as the substrate for the ADP- 
ribosylation reaction, before starting the enzymatic assay by the addi- 
tion of 250 PM NAD’. 
ADH activity was monitored following the reduction of NAD’ to 
NADH. recording the fluorescence signal above 430 nm after excita- 
tion at 3 13 and 366 nm, respectively. 10 mU ADH were preincubated 
for 30 min at 37°C in the presence of 100 mM sodium phosphate 
buffer (pH 8.5). 0.6 M ethanol, 6.2 mM semicarbazide and 1 PM 
NAD’ as the substrate for the ADP-ribosylation reaction. The enzy- 
matic reaction was started with 200 PM NAD’. 
LDH activity was determined by incubating 0.5 mU LDH in 0.1 M 
triethylammonium-buffer (pH 8.0) containing 1 mM EDTA, 1 mM 
lactate and 1 PM NAD’ to allow the ADP-ribosylation reaction for 
30 min at 37OC. Starting the enzymatic LDH reaction by adding 400 
PM NAD’ the reduction of NAD’ to NADH was followed as de- 
scribed above. 
2.3. Pretreatment wjith N-ethylmalelmide (NEMO 
The different enzymes were preincubated as described above with 
increasing concentrations of NEM. After IO min at 37°C the enzy- 
matic reaction was started by the addition of NAD’. 
SIN-1 + + + 
Fig. 1. Auto-ADP-ribosylation of various dehydrogenases. [“P]ADP- 
ribosylation of different dehydrogenases (lactate dehydrogenase 
(LDH); alcohol dehydrogenase (ADH) and glyceraldehyde-3-phos- 
phate dehydrogenase (GAPDH)) in the presence or absence of 250yM 
SIN-1 was carried out as described in section 2. The figure is represen- 
tative for three similar experiments. 
2.4. [32P]ADP-ribosylation 
ADP-ribosylation was mainly carried out as previously described 
[l I]. The enzymes (10 ,&assay) were incubated m 100 mM HEPES 
(pH 7.5). 0.5 ,Ki [‘*PINAD’. 1 PM cold NAD’ and in the absence or 
presence of 250 PM SIN-1 for 30 min at 37°C. For determination of 
the auto-ADP-ribosylation of GADPH 1 mM DTT was added, to 
prevent autoxidation of the enzyme. After protein precipition (10% 
TCA final), resulting pellets were washed twice with cold water-satu- 
rated-ether and were resolved in a 10% sodium dodecyl sulfate-poly- 
acrylamide gel [13]. Radioactivity was quantified using the phosphor 
image system (Molecular Dynamics) [14]. 
3. RESULTS AND DISCUSSION 
NO spontaneously released from SIN-l has been 
shown to stimulate the auto-ADP-ribosylation of 
GAPDH in a concentration-dependent fashion [ 11,121. 
Incubation of GAPDH with [32P]NAD+ resulted in a 
low basal incorporation of [32P]ADP-ribose into 
GAPDH, whereas addition of 250 PM SIN-l greatly 
enhanced the auto-ADP-ribosylation reaction of the en- 
zyme (Fig. 1). Generally, stimulation by 250 ,uM SIN- 1 
led to a 5-fold increased incorporation of radioactivity 
compared to control incubation receiving no SIN-l 
(Table I). Looking at GAPDH enzyme activity, known 
to be inhibited by the described NO-stimulated auto- 
ADP-ribosylation reaction [ 121, we detected a decreased 
enzymatic activity (Table I). 
To determine the ability of alcohol dehydrogenase to 
be ADP-ribosylated in the presence of NO, 10 pug homo- 
geneous ADH was incubated with [32P]NAD+ as de- 
scribed in section 2. As shown in Fig. 1 a low basal 
incorporation of radioactivity was detected in control 
incubations (without NO-donor), whereas addition of 
250 ,uM SIN-1 resulted in a minor, roughly 2-fold in- 
creased incorporation of [32P]ADP-ribose into the pro- 
tein (Table I and Fig. 1). Using rat liver cytosol instead 
of purified enzyme we observed an incorporation of 
[32P]ADP-ribose in a 40 kDa protein stimulated by SIN- 
1. Since the molecular mass of 40 kDa is identical with 
the subunit molecular mass of ADH, the protein even- 
tually becomes a target for ADP-ribosylation in the 
cytosolic fraction. Recently it has been reported that 
Table I 
Effect of SIN-1 on auto-ADP-ribosylation and enzymatic activity of 
different dehydrogenases. 
Radioactivity 
(% control) 
Enzyme activity 
(% control) 
Crystallographic studies revealed that the coenzyme 
binding domain of GAPDH is structurally similar to 
corresponding domains of equine liver alcohol dehydro- 
genase (ADH) and lactate dehydrogenase (LDH) [ 151. 
Furthermore these dehydrogenases also contain SH- 
groups at or near their active sites [16], suggesting that 
NO might be able to stimulate the transfer of ADP- 
ribose from NAD’ to these dehydrogenases as well. 
LDH 100 100 
LDH + 250 PM SIN-l 126 f 14 97 f 15.9 
ADH 100 100 
ADH + 250 PM SIN-l 172 + 36 47.5 f 6.2 
GAPDH 100 100 
GAPDH + 250 PM SIN-l 504 _+ 192 37.5 f 5.7 
Auto-ADP-ribosylation and enzymatic activity of lactate dehydroge- 
nase (LDH), alcohol dehydrogenase (ADH) and glyceraldehyde-3- 
phosphate dehydrogenase Auto-ADP-ribosylation and enzymatic ac- 
tivity of lactate dehydrogenase (LDH), alcohol dehydrogenase (ADH) 
and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were de- 
termined as described in section 2. Values represent mean + S.E. of 
three individual experiments. 
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several mitochondrial dehydrogenases are affected in 
their activity by pathophysiological conditions [17], 
probably involving NO. This prompted us to investigate 
the effect of SIN-l on ADH-activity as well. Measuring 
ADH activity after allowing ADP-ribosylation to take 
place by incubation with 250 PM SIN-1 we observed a 
50% decreased enzymatic activity (Table I). Even higher 
concentrations of SIN-l or employing another NO- 
donor like sodium nitroprusside did not result in en- 
hanced inhibition under these conditions (data not 
shown). In comparison to GADPH, ADH is less sus- 
ceptible to NO stimulated ADP-ribosylation and to a 
similar degree, enzymatic activity is less affected by NO. 
Similar experiments were carried out using lactate dehy- 
drogenase. Interestingly, almost no stimulation of 
ADP-ribosylation of LDH was detected by addition of 
250 ,uM SIN-l (Fig. 1) and furthermore, LDH activity 
was completely unaffected by NO, released from 250 
,uM SIN-l (Table I). 
To explain the differences in the accessibility of the 
chosen dehydrogenases towards ADP-ribosylation as- 
sociated with a variable degree of enzyme inhibition we 
tried to correlate the reactivity of the essential cysteine 
groups in the enzyme to their sensitivity towards NEM. 
As shown in Fig. 2 preincubation of GAPDH with 
low concentrations N-ethylmaleimide (NEM) before 
starting the enzymatic reaction resulted in inhibition of 
GAPDH activity at low concentrations of the SH-al- 
kylating reagent. A concentration of 50 PM NEM to- 
tally inhibited enzyme activity. Incubating ADH with 
the same concentration of NEM revealed only a minor 
decrease in ADH activity (gbout 20% inhibition), and 
no complete inhibition of ADH activity was achieved at 
higher concentrations of NEM (Fig. 2). Noteworthy, 
addition of relatively high concentrations of NEM did 
not affect LDH activity (Fig. 2). To sum up, LDH was 
neither inhibited by NEM nor by the NO donor SIN-l. 
Furthermore, NO-stimulated auto-ADP-ribosylation 
of LDH was not detectable. 
Recently we reported that the NO stimulated ADP- 
ribosylation of GADPH is enhanced by the addition of 
physiological concentrations of reducing agents such as 
glutathione (GSH) [ 181. For this reason we investigated 
the ADP-ribosylation of the chosen dehydrogenases 
also in the presence of dithiothreitol or GSH. Incubat- 
ing ADH now with 250 PM SIN-l, [32P]NAD+ and 1 
mM DTT did not result in any increased incorporation 
of radioactivity at all, compared to the assay when DTT 
was omitted (data not shown). In respect to LDH, the 
basal auto-ADP-ribosylation of LDH was even de- 
creased in the presence of reducing agents (data not 
shown). Probably the SH-groups of the reducing agents 
may have a stronger affinity towards NO compared to 
the essential SH-group of ADH. This may result in 
S-nitrosylation of the reducing agent and therefore may 
prevent the NO-stimulated ADP-ribosylation of the en- 
zyme. However, reducing conditions are necessary to 
0 1 0 
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Fig. 2. Inhibition of dehydrogenase activity by Wethylmaleimide 
(NEM). After preincubating the chosen dehydrogenases with increas- 
ing concentrations of NEM (10 min, 3TC) the enzymatic activities 
were determined as outlined in section 2. Data are means + S.E. from 
three different experiments. 
prevent oxidation of GAPDH and ADP-ribosylation of 
GAPDH only takes place in the presence of DTT or 
GSH [18]. Therefore the essential thiol group in 
GAPDH is much more susceptible to ADP-ribosylation 
and is a much more likely target under more physiolog- 
ical conditions compared to ADH or LDH. 
Since the NAD’ binding site of the different dehydro- 
genases is almost similar, we propose that the accessibil- 
ity of the SH-group under our conditions seems to be 
an important restriction for the ADP-ribosylation reac- 
tion. This assumption is supported by our finding, that 
stimulation of the ADP-ribosylation reaction and en- 
zyme inhibition brought about by NO correlates with 
the efficiency of NEM to cause similar enzyme inhibi- 
tion. 
The efficiency of NEM to block NO-stimulated auto- 
ADP-ribosylation of GAPDH has been demonstrated 
in the past, for the basal as well as for the stimulated 
ADP-ribosylation reaction [ 12,181. Here we show, that 
the sensitivity of different dehydrogenases towards 
NEM correlates with the ability of NO to cause ADP- 
ribosylation of the chosen enzymes. Considering a reac- 
tive SH group as well as a NAD’-binding site as a 
prerequisite for this reaction, we now clearly demon- 
strate that the reactivity of the accessible SH-group is 
another important regulatory component. The SH- 
group of LDH near the active site may be masked and 
therefore no cleavage of NAD’ could be catalyzed by 
NO. 
In conclusion, NO-stimulated auto-ADP-ribosyla- 
tion is not a nonspecific reaction carried out by all 
dehydrogenases, only GAPDH and, to a minor extent, 
ADH in the absence of reducing cofactors seem to be 
23 
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susceptible to NO-stimulated ADP-ribosylation and en- 
zyme inhibition. Inhibition of GAPDH-activity by ex- 
ogenous addition or endogenously generated NO re- 
cently was demonstrated using the B-cell line RINm5F 
[19]. These findings indicate a possible link between 
NO-stimulated auto-ADP-ribosylation of GAPDH, en- 
zyme-inhibition and cytotoxic NO effects. NO mediated 
cytotoxicity towards pancreatic /J-cells is related to inhi- 
bition of mitochondrial respiration [20] and inhibition 
of glycolysis [19]. Therefore, altered energy supply and 
cytotoxic NO effects are possibly correlated. 
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